High Tide CEO, Board Purchase Shares After New Lending Deal

Raj Grover bought more High Tide (HITI ) shares last week. So did several members of the board and senior leadership team — all on the open market, at prevailing market prices, and all within days of the company announcing a term sheet for a $40 million credit line with one of Canada’s Big Five banks.

Open-market insider purchases carry a different weight than option exercises or equity compensation grants. There’s no structural discount, no pre-arranged plan, and no reason to buy other than belief that the stock is worth more than its current price. That the CEO and board moved in a concentrated three-day window, then chose to announce the trades alongside specific operational milestones, makes the stated rationale more legible than most insider filings.

What They Bought

According to a press release filed with the SEC as Exhibit 99.1 and distributed via CNW Group on May 11, 2026, officers, directors, and consultants of High Tide collectively acquired 90,882 common shares on the open market between May 6, 2026 and May 8, 2026 at an average price of $3.39 per share — a combined outlay of roughly $308,000. Following the purchases, insiders and certain consultants collectively hold 7,720,360 common shares, which the company says represents approximately 8.8% of High Tide’s total issued and outstanding shares as of May 11, 2026.

High Tide trades on the Nasdaq and the TSX Venture Exchange under the ticker HITI.

Grover acknowledged his own role directly in a statement accompanying the announcement, saying he was “very pleased to have increased my own ownership position alongside several members of our Board and leadership team following these developments” — framing the purchases as a direct response to events in the prior week.

The Operational Context

Three things drove the timing.

The most significant is the lending relationship. High Tide announced that it has secured a term sheet for $40 million in credit facilities with a Big Five Canadian chartered bank acting as new senior lender. That’s worth separating from routine credit renewals: Canada’s major banks have generally kept their distance from cannabis companies on senior secured lending, given the sector’s regulatory complexity and capital-markets profile. A term sheet at that tier signals the relationship is substantive, even before closing. The company hasn’t disclosed which institution is involved, and the credit agreement remains unsigned — but such announcements reflect a relationship that’s advanced enough to communicate publicly.

Second, Remexian. High Tide completed the acquisition of a majority stake in Remexian Pharma GmbH in September 2025, entering Germany’s medical cannabis market. The subsidiary distributed a record 7.6 tonnes of medical cannabis in the most recent quarter. According to data the company attributes to Germany’s federal drug regulator for the first quarter of 2026, Remexian’s share of the German market has risen above 14% — which the company says more than doubles its position since the acquisition closed. Germany is Europe’s largest medical cannabis market, and if Remexian’s trajectory holds, the international expansion is delivering more than early momentum.

Third, Grover cited a completed institutional investor roadshow across three cities. Roadshows move positioning, not the income statement — but alongside a Big Five term sheet, they suggest High Tide is actively managing its institutional investor relationships.

For context on High Tide’s retail footprint: its Canna Cabana subsidiary currently operates 221 stores across British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, plus one international location in Germany — which the company describes as making it the largest cannabis retail chain in Canada by store count. The company said in its fiscal 2025 annual results, filed in January 2026, that it planned to open another 20 to 30 locations in calendar 2026. Competitors such as SNDL Inc. (SNDL ) operate across overlapping provinces, though none have matched Canna Cabana’s current domestic store count.

Reading the Signal

Insider buying is a signal, but reading it requires care. The 90,882 shares represent a modest slice of total shares outstanding — the 8.8% aggregate insider stake, implied at roughly 87.7 million shares outstanding, is a meaningful ownership alignment but not uncommon for a founder-led company. The average buy price of $3.39 per share places these purchases at current trading levels, which matters: market-rate buying says more about conviction than discounted option exercises.

What the purchases don’t resolve: the $40 million facility is still a term sheet, not a signed agreement. The Germany market share figure is company-attributed regulatory data, not yet reflected in audited quarterly financials. And while record Remexian distribution volumes are operationally meaningful, the segment’s full contribution to consolidated results won’t be visible until High Tide files its next financial statements on SEDAR+ and EDGAR.

What the purchases do say is that the people with the closest view of the company’s business decided the current share price didn’t reflect what they see. The backdrop Grover described — a Big Five bank relationship, a more-than-doubled German market share, and a record quarter at Remexian — is a more concrete set of catalysts than the usual “intrinsic value” language attached to insider buying announcements. How those catalysts translate to the balance sheet is the next thing to watch.